Altimmune
ALT
ALT
41 hedge funds and large institutions have $6.83M invested in Altimmune in 2017 Q2 according to their latest regulatory filings, with 12 funds opening new positions, 9 increasing their positions, 12 reducing their positions, and 42 closing their positions.
New
Increased
Maintained
Reduced
Closed
more ownership
Funds ownership: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
71% less first-time investments, than exits
New positions opened: 12 | Existing positions closed: 42
100% less call options, than puts
Call options by funds: $0 | Put options by funds: $387K
Holders
41
Holding in Top 10
1
Calls
–
Puts
$387K
Top Buyers
| 1 | +$586K | |
| 2 | +$357K | |
| 3 | +$339K | |
| 4 |
ECM
Element Capital Management
New York
|
+$151K |
| 5 |
Goldman Sachs
New York
|
+$108K |
Top Sellers
| 1 | -$765K | |
| 2 | -$738K | |
| 3 | -$411K | |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
-$380K |
| 5 |
Axa
Paris,
France
|
-$294K |